Nature of Operations and Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Revenue Disaggregated by Revenue Type

The following table presents our revenue disaggregated by revenue type:

(in millions)	Three Months Ended March 31, 2018
	Ratings		Market Intelligence		Platts		Indices		Intersegment Elimination 1			Total
Subscription	$	—	$	424	$	181	$	33	$	—		$	638
Non-transaction	380		—		—		—		(28		)	352
Non-subscription / Transaction	368		8		2		—		—			378
Asset-linked fees	—		5		—		131		—			136
Sales usage-based royalties	—		—		13		50		—			63
Total revenue	$	748	$	437	$	196	$	214	$	(28	)	$	1,567
Timing of revenue recognition
Services transferred at a point in time	$	368	$	8	$	2	$	—	$	—		$	378
Services transferred over time	380		429		194		214		(28		)	1,189
Total revenue	$	748	$	437	$	196	$	214	$	(28	)	$	1,567

(in millions)	Three Months Ended March 31, 2017 2
	Ratings		Market Intelligence		Platts		Indices		Intersegment Elimination 1			Total
Subscription	$	—	$	385	$	172	$	31	$	—		$	588
Non-transaction	341		—		—		—		(25		)	316
Non-subscription / Transaction	373		11		3		—		—			387
Asset-linked fees	—		6		—		108		—			114
Sales usage-based royalties	—		—		16		32		—			48
Total revenue	$	714	$	402	$	191	$	171	$	(25	)	$	1,453
Timing of revenue recognition
Services transferred at a point in time	$	373	$	11	$	3	$	—	$	—		$	387
Services transferred over time	341		391		188		171		(25		)	1,066
Total revenue	$	714	$	402	$	191	$	171	$	(25	)	$	1,453

¹  Intersegment eliminations mainly consists of a royalty charged to Market Intelligence for the rights to use and distribute content and data developed by Ratings.

²  As noted above, amounts for the three month ended March 31, 2017 were not adjusted under the modified retrospective transition method applied to our revenue contracts with customers as of January 1, 2018.

Schedule of Components of Other (Income) Expense, Net [Table Text Block]

The components of other (income) expense, net for the three months ended March 31 are as follows:

(in millions)	2018			2017
Other components of net periodic benefit cost	$	(8	)	$	(9	)
Net loss from investments 1	4			—
Other (income) expense, net	$	(4	)	$	(9	)

¹  Primarily relates to the change in fair value of CRISIL's investment in Care Ratings Limited ("CARE"). The investment balance of CARE as of March 31, 2018 and December 31, 2017 is $49 million and $54 million, respectively, and is included in non-current assets in our consolidated balance sheets.